s-methylisothiopseudouronium has been researched along with Diabetes Mellitus, Type 1 in 1 studies
S-methylisothiopseudouronium: inhibits nitric oxide synthase; structure in first source
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roganović, J | 1 |
| Radenković, M | 1 |
| Tanić, N | 2 |
| Petrović, N | 1 |
| Stojić, D | 1 |
1 other study available for s-methylisothiopseudouronium and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Impairment of acetylcholine-mediated endothelium-dependent relaxation in isolated parotid artery of the alloxan-induced diabetic rabbit.
Topics: Acetylcholine; Alloxan; Animals; Arteries; Bradykinin; Cyclooxygenase Inhibitors; Diabetes Mellitus, | 2011 |